Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04779827 · ClinicalTrials.gov registry record · NA

Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks

A NA study of COVID-19 and Heart Diseases, sponsored by University of Pennsylvania.

Active
Registry status
NA
Development phase
4,476
Enrollment target
1
Study location

NCT04779827: Active NA study of COVID-19 and Heart Diseases, sponsored by University of Pennsylvania.

NCT04779827 is a NA study of COVID-19 and Heart Diseases that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 4,476 participants, below the 38,450-participant average among 298 other COVID-19 trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04779827, a NA study of COVID-19 and Heart Diseases, is active but no longer recruiting, sponsored by University of Pennsylvania.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
4,476 participants
Enrollment target
1
Study location

Study Summary

Social technologies for health have already become essential means for providing underserved populations greater social connectedness and increased access to novel health information. However, these technologies have also had negative unintended consequences. The resulting digital divide in social technology takes many forms - from explicit racism that excludes African American and Latinx populations from the resources enjoyed by White and Asian members of online communities, to self-segregation for the purposes of identity preservation and community-building that unintentionally results in limited informational diversity in underserved communities. The result is an often unnoticed, but highly consequential compounding of inequities. This research seeks to use an online social network approach to address these challenges, in which the investigators demonstrate how reducing the online levels of network centralization and network homophily among African American community members directly increases their productive engagement with health-promoting information.

Primary Outcome

COVID-19 vaccination attitude scale, which is a self-reported scale measuring participants' attitudes toward COVID-19 vaccination. The scale is consisted of 5 questions (e.g., "How much confidence do you have that the COVID-19 vaccine in the U.S. is safe and effective?") with responses ranging from 1 (No confidence at all) to 5 (A great deal of confidence); a higher average score means a more positive attitude in favor of COVID-19 vaccination.

Interventions

  • BEHAVIORAL Online Social Network and Collective Intelligence Intervention
  • BEHAVIORAL Independent Control

Study Locations (1)

Pennsylvania

  • Annenberg School for Communication - Philadelphia

Trial Details

FieldValue
Enrollment Target 4,476 participants
Start Date 2021-05-04
Est. Completion 2027-03-30
Phase NA
University of Pennsylvania

1,423 total trials

What the registry record for NCT04779827 still lists

NCT04779827 is an interventional study that assigns participants to a tested intervention. Its 4,476 participants enrollment target places it among the larger protocols in the corpus, below the 38,450-participant average among 298 other COVID-19 trials with a reported enrollment target (88% lower).

The record links to 3 conditions, with COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which Online Social Network and Collective Intelligence Intervention is the first listed.

NCT04779827 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04779827 about?

NCT04779827 is a clinical study titled "Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks". Social technologies for health have already become essential means for providing underserved populations greater social connectedness and increased access to novel health information. However, these technologies have also had negative unintended consequences. The resulting digital divide in social t...

What is the current status of trial NCT04779827?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 4,476 participants. The study started on 2021-05-04. Estimated completion is 2027-03-30.

What conditions does trial NCT04779827 study?

This clinical trial studies the following conditions: COVID-19, Heart Diseases, Vaccination Refusal.

What interventions are being tested in trial NCT04779827?

The interventions under investigation include: Online Social Network and Collective Intelligence Intervention (BEHAVIORAL), Independent Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT04779827?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04779827 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04779827's enrollment target sits among peer trials

4,476 31st of 298 higher than 268 of 298 other COVID-19 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06252753 · 4,490 participants

    Observational Study Protocol: LIVER-R

  • NCT06533111 · 4,500 participants · NA

    Improving Surgical Patient Outcomes Through Implementation of a SemiStructured Intraoperative Anesthesia Handoff Tool

  • NCT06588452 · 4,500 participants

    Manual Versus AI-Assisted Clinical Trial Screening Using Large-Language Models

  • NCT07165028 · 4,500 participants · Phase 3

    A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04779827, the US trial registry maintained by the National Library of Medicine. NCT04779827 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.